David Westenberg
Stock Analyst at Piper Sandler
(1.66)
# 1606
Out of 5,218 analysts
160
Total ratings
54.22%
Success rate
13.31%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Akoya Biosciences | Reiterates: Overweight | 4 3 | 2.27 | 32.16% | 7 | Nov 19, 2024 | |
Natera | Maintains: Overweight | 150 200 | 166.11 | 20.4% | 13 | Nov 18, 2024 | |
Tempus AI | Reiterates: Neutral | 40 70 | 40.92 | 71.07% | 2 | Nov 12, 2024 | |
Pacific Biosciences | Maintains: Neutral | 2 3 | 1.96 | 27.55% | 6 | Nov 11, 2024 | |
Illumina | Maintains: Overweight | 195 185 | 143.9 | 28.56% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 26 22 | 19.54 | 12.59% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 85 75 | 61.38 | 22.19% | 9 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 9 | 6.19 | 37.32% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 7 | 6.29 | 11.29% | 10 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 520 435 | 432.18 | 0.65% | 9 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 150 165 | 155.09 | 6.39% | 5 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 235 240 | 232.46 | 3.24% | 2 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 195 210 | 178.34 | 17.75% | 9 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 34 | 34.67 | -1.93% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 18 | 12.14 | 44.15% | 9 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 16 | 12.12 | 32.01% | 8 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 20 | 17.72 | 12.87% | 7 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 2.34 | 28.21% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 5 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 170 165 | n/a | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 30 | n/a | n/a | 2 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 44 | n/a | n/a | 2 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 21, 2017 |